ChemPharmaServe

www.chempharmaserve.com/

ChemPharmaServe Ltd is a solution provider established to help emerging pharmaceutical and biotech companies by resolving their critical compound supply needs during the pre-clinical and clinical phases of drug development.

Founded in 2004, ChemPharmaServe provides a comprehensive range of consultancy and support services to help removing the material supply tasks from the critical path including:

Sourcing any quantity of active drugs or intermediates
Outsourcing the custom synthesis of key compounds
Process R&D for new drugs
Manufacture of clinical trial materials to GMP
Supply chain management
Project management and support
Conduct costing studies and helping clients to achieve favourable cost of goods
Identification of enabling technologies and assisting with technology transfer

ChemPharmaServe has also forged direct and strong relationships with a select group of experts and companies around the world who contribute to realising clients' objectives.

Staff

Hooshang Zavareh, CEO

Hooshang has considerable experience in research, process development, technology transfer and outsourcing, gained over 25 years. Following a long career with Dow Chemical in the UK and USA, he worked with Chiroscience and Celltech and led process development teams who developed Chirocaine and other key NCEs. He has also worked with Amedis Pharmaceuticals in Cambridge and managed all their chemistry outsourcing needs. Hooshang gained his MSc and PhD from Sheffield University and subsequently carried out postdoctoral research at Sheffield and University College London.

Contact details

14 Cundell Drive,
Cottenham
Cambridge,
CB4 8RU

Tel: +44 (0) 1954 252789
Articles relating to ChemPharmaServe

There are currently no articles relating to ChemPharmaServe
Subscribe

 

Corporate profiles

 • Arachnova


Robert Gristwood, PhD
Founder, scientific, technical


Arachnova Limited identifies and patents proprietary new uses for existing compounds, and validates them using a carefully orchestrated outsourced strategy. It is a privately held largely financed by Renaissance Ventures LP, a specialized European biomedical equity fund. Arachnova has an experienced

[Arachnova's profile]


Top20 Index




Currently: 71.78


Create Publisher Site
This Publisher Website ( slot3.siliconfenbusiness.com ) does not exist in Direct-Link-Ads.com. Please create it now.